Clinical trials
Recruiting Breast Neoplasms trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Tata Memorial Centre | 2 |
| All India Institute of Medical Sciences, Bhubaneswar | 1 |
| Basavatarakam Indo American Cancer Hospital & Research Institute | 1 |
| Bristol-Myers Squibb | 1 |
| Dr. Tabassum Wadasadawala | 1 |
| Hoffmann-La Roche | 1 |
| Natureceuticals Sdn Bhd | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 16 |
| Neoplasm Metastasis | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Breast Neoplasms, Male | 1 |
| Radiation Injuries | 1 |
| Recurrence | 1 |
| Unilateral Breast Neoplasms | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.